Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1451707

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1451707

Nucleotides Market Report by Type, Technology, Form, Application, and Region 2024-2032

PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2999
PDF & Excel (5 User License)
USD 3999
PDF & Excel (Corporate License)
USD 4999

Add to Cart

The global nucleotides market size reached US$ 718.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,251.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032.

Nucleotides are the basic building block of nucleic acids, such as ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). They enhance various metabolic processes and the formation of the structure of proteins synthesized in the cell. They act with enzymes to speed up biochemical reactions in the body. They also aid in the biosynthesis of macromolecules and cell signaling through interaction with purinergic receptors. In addition, nucleotides assist in encoding, transmitting, and expressing genetic information in the body. As they provide a high degree of potency and selectivity against the herpes group of viruses, nucleotides are used as antiviral or anticancer agents in several medicines.

Nucleotides Market Trends:

At present, there is a rise in the utilization of nucleotide supplements in dairy products, such as yogurt and condensed and powdered milk, across the globe. This, along with the growing availability of these supplements in the form of powdered fluids, represents one of the key factors driving the market. Besides this, the increasing employment of nucleotides in nutraceuticals to treat conditions, such as poor nutrition, stress, and hypertension, is contributing to the growth of the market. In addition, the rising application of nucleotides in diagnostic research to diagnose the presence of various viral diseases and types of cancer is propelling the growth of the market. Moreover, there is an increase in the demand for nucleotides in animal feed to maintain metabolism rates in livestock. This, coupled with the growing awareness among the masses about the harmful impacts of animal diseases, is positively influencing the market. Apart from this, the escalating demand for nucleotides to enhance the recovery of intestinal epithelial cells, which helps boost the immunity system, is offering a positive market outlook. Additionally, the increasing usage of ribonucleotides in infant food formulations is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nucleotides market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology, form and application.

Breakup by Type:

Food Grade

Lab Grade

Industry Grade

Others

Breakup by Technology:

TaqMan Allelic Discrimination

Gene Chips and Microarrays

SNP by Pyrosequencing

Others

Breakup by Form:

Liquid

Powder

Breakup by Application:

Pharmaceutical

Food and Animal Feed Additives

Drug Discovery

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being CJ CheilJedang Corporation, Exotic Biosolutions, F. Hoffmann-La Roche AG, Jena Bioscience GmbH, Koninklijke DSM N.V., Lallemand Inc., Meridian Bioscience Inc., Nanjing Biotogether Co. Ltd., Ohly GmbH (Associated British Foods plc), Promega Corporation, Starlake Bioscience Co. Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global nucleotides market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global nucleotides market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the form?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global nucleotides market and who are the key players?
  • What is the degree of competition in the industry?
Product Code: SR112024A6472

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nucleotides Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Food Grade
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Lab Grade
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Industry Grade
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 TaqMan Allelic Discrimination
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gene Chips and Microarrays
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 SNP by Pyrosequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Form

  • 8.1 Liquid
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Powder
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Pharmaceutical
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Food and Animal Feed Additives
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Drug Discovery
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 CJ CheilJedang Corporation
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Exotic Biosolutions
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 F. Hoffmann-La Roche AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Jena Bioscience GmbH
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Koninklijke DSM N.V.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Lallemand Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Meridian Bioscience Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Nanjing Biotogether Co. Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Ohly GmbH (Associated British Foods plc)
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Promega Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Starlake Bioscience Co. Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

Product Code: SR112024A6472

List of Figures

  • Figure 1: Global: Nucleotides Market: Major Drivers and Challenges
  • Figure 2: Global: Nucleotides Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Nucleotides Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Nucleotides Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Nucleotides Market: Breakup by Form (in %), 2023
  • Figure 7: Global: Nucleotides Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Nucleotides Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Nucleotides (Food Grade) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Nucleotides (Food Grade) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Nucleotides (Lab Grade) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Nucleotides (Lab Grade) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Nucleotides (Industry Grade) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Nucleotides (Industry Grade) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Nucleotides (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Nucleotides (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Nucleotides (TaqMan Allelic Discrimination) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Nucleotides (TaqMan Allelic Discrimination) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Nucleotides (Gene Chips and Microarrays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Nucleotides (Gene Chips and Microarrays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Nucleotides (SNP by Pyrosequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Nucleotides (SNP by Pyrosequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Nucleotides (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Nucleotides (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Nucleotides (Liquid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Nucleotides (Liquid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Nucleotides (Powder) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Nucleotides (Powder) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Nucleotides (Pharmaceutical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Nucleotides (Pharmaceutical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Nucleotides (Food and Animal Feed Additives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Nucleotides (Food and Animal Feed Additives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Nucleotides (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Nucleotides (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Nucleotides (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Nucleotides (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Nucleotides Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Nucleotides Industry: SWOT Analysis
  • Figure 87: Global: Nucleotides Industry: Value Chain Analysis
  • Figure 88: Global: Nucleotides Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nucleotides Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Nucleotides Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Nucleotides Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Nucleotides Market Forecast: Breakup by Form (in Million US$), 2024-2032
  • Table 5: Global: Nucleotides Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Nucleotides Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Nucleotides Market: Competitive Structure
  • Table 8: Global: Nucleotides Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!